Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Youssef

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2024
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases TreatmentMichael Dohopolski, Luiza Giuliani Schmitt, Soummitra Anand, et al.
Cancers|April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case SeriesMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Clinical Trials (London, England)|July 7, 2011
Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learnedJennifer Steel, David A Geller, Allan Tsung, et al.
Advances in Radiation Oncology|July 4, 2025
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score-Matched AnalysisMichael Dohopolski, Luiza Giuliani Schmitt, Jill de Vis, et al.
BMC Public Health|June 25, 2026
A community-engaged public health research and outreach program for immigrant and racialized workers in meat processing during the COVID-19 pandemicGabriel E Fabreau, Eric Norrie, Linda Holdbrook, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric ResponseLuiza Giuliani Schmitt, Michael Dohopolski, Jill de Vis, et al.
Nature Cell Biology|August 1, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationGao Guo, Ke Gong, Nicole Beckley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2024
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases TreatmentMichael Dohopolski, Luiza Giuliani Schmitt, Soummitra Anand, et al.
Cancers|April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case SeriesMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Clinical Trials (London, England)|July 7, 2011
Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learnedJennifer Steel, David A Geller, Allan Tsung, et al.
Advances in Radiation Oncology|July 4, 2025
Comparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score-Matched AnalysisMichael Dohopolski, Luiza Giuliani Schmitt, Jill de Vis, et al.
BMC Public Health|June 25, 2026
A community-engaged public health research and outreach program for immigrant and racialized workers in meat processing during the COVID-19 pandemicGabriel E Fabreau, Eric Norrie, Linda Holdbrook, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric ResponseLuiza Giuliani Schmitt, Michael Dohopolski, Jill de Vis, et al.
Nature Cell Biology|August 1, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationGao Guo, Ke Gong, Nicole Beckley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 5